Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.

Quiambao BP, Ambas C, Diego S, Bosch Castells V, Korejwo J, Petit C, Houillon G.

Vaccine. 2019 Apr 10;37(16):2268-2277. doi: 10.1016/j.vaccine.2019.02.083. Epub 2019 Mar 16.

2.

Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months.

Javadekar B, Ghosh A, Kompithra RZ, Awasthi S, Perminova O, Romanenko V, Rodnikova V, Kharit S, Thollot Y, Bosch-Castells V, Goldstein A, Dubey H.

Indian Pediatr. 2018 Dec 15;55(12):1050-1055.

3.

A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants.

Fukushima S, Kikuchi H, Miyazu M, Hamada A, Ouchi K, Takagi H, Mihara H, Sasaki T, Oka H, Bosch-Castells V, Oster P.

Jpn J Infect Dis. 2018 Nov 22;71(6):402-407. doi: 10.7883/yoken.JJID.2017.277. Epub 2018 Jun 29.

4.

Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study.

Vu TD, Nguyen QD, Tran HTA, Bosch-Castells V, Zocchetti C, Houillon G.

Int J Infect Dis. 2018 Jan;66:137-142. doi: 10.1016/j.ijid.2017.10.010. Epub 2017 Nov 27.

5.

Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil.

Medeiros R, Jusot V, Houillon G, Rasuli A, Martorelli L, Kataoka AP, Mechlia MB, Le Guern AS, Rodrigues L, Assef R, Maestri A, Lima R, Rotivel Y, Bosch-Castells V, Tordo N.

PLoS Negl Trop Dis. 2016 Sep 21;10(9):e0004920. doi: 10.1371/journal.pntd.0004920. eCollection 2016 Sep.

6.

Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.

Kim DS, Jang GC, Cha SH, Choi SH, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Bang J, Naimi Z, Bouckenooghe A, Bosch-Castells V, Houillon G.

Pediatr Infect Dis J. 2016 Feb;35(2):e60-4. doi: 10.1097/INF.0000000000000967.

PMID:
26535878
7.

A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.

Miyazu M, Kikuchi H, Hamada A, Fukushima S, Ouchi K, Bosch Castells V, Mihara H, Bonnet MC.

Vaccine. 2015 Nov 27;33(48):6697-702. doi: 10.1016/j.vaccine.2015.10.086. Epub 2015 Oct 28.

8.

A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.

Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A.

Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6.

9.

Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.

Khalil M, Al-Mazrou Y, Findlow H, Chadha H, Bosch Castells V, Oster P, Borrow R.

Vaccine. 2014 Sep 29;32(43):5715-21. doi: 10.1016/j.vaccine.2014.08.026. Epub 2014 Aug 20.

PMID:
25151042
10.
11.

Supplemental Content

Loading ...
Support Center